Catalyst Wire Dossier Catalyst Wire Dossier

TLR7 agonist

toll-like receptor 7 agonist
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLR7 agonist, covering 2021-11-18 to 2021-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases [Phase 1, Phase 2]

See pricing